Audience
Pharmaceutical and biotech research teams looking for a tool to monitor, analyze and act on oncology clinical-trial data, biomarker trends and drug-pipeline intelligence
About LARVOL CLIN
The LARVOL CLIN platform delivers comprehensive, AI-powered data intelligence and analytics tailored for oncology and drug-development professionals by aggregating more than 100,000 cancer clinical trials along with detailed results, digitized Kaplan-Meier curves and forest plots, and real-time social-media reactions from over 5,000 oncologists. Users can search by condition, intervention, or trial ID within a single streamlined interface offering expert-curated insights and visual dashboards for data-driven decision-making. The system also covers conference tracking, biomarker and diagnostics databases, and market-intelligence reports from over 25,000 sources, including regulatory communications, clinical-trial registries, and scientific congresses. Built to support pharma and biotech teams in understanding trial outcomes, trends, mechanisms of action, biomarkers, and disease pipelines, the platform integrates deep search filters, heat-maps, real-time alerts, and more.